Doxycycline Hyclate Solicitation
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SPE2D2-25-R-0004
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is soliciting offers for Doxycycline Hyclate 100 MG tablets in various count sizes (20, 30, 50, 100, 210, 300, 400, 500, and 1000 tablets) through a national requirements contract. This solicitation will establish a pharmaceutical supply contract serving the Department of Defense, Veterans Affairs, Indian Health Service, and Bureau of Prisons via Pharmaceutical Prime Vendor (PPV) programs. Contractors must provide FDA-approved products with an "A" therapeutic equivalence rating and meet specific technical requirements, including unit-of-use barcode labeling and database registration with RXNorm, First Data Bank, Multum, and Medi-Span. The solicitation (SPE2D2-25-R-0004) requires electronic proposal submission through DIBBS, with offers due by February 5, 2025, at 3:00 PM EST. Proposals will likely be evaluated based on compliance with technical specifications, FDA approval status, distribution capabilities, and pricing.
The solicitation is not set aside for any specific business category and will be open to qualified pharmaceutical manufacturers and distributors. The contract will have a one-year base period with four one-year option periods, with contract performance commencing 45 days after award and pricing effective 15 days thereafter (approximately April 28, 2025). Contractors must establish business-to-business agreements with PPV contractors and ensure complete order fulfillment within 15 calendar days of order receipt. While specific award value is not disclosed, the contract involves national-level pharmaceutical distribution across multiple federal healthcare systems. The place of performance will be through the established Pharmaceutical Prime Vendor distribution network, enabling widespread product availability across various federal healthcare facilities nationwide.
Notice text
5 versions
Update #5 · Latest ·
Amendment 0004 has been made because Amendment 0003 did not require an offeror signature to acknowledge the change of language to the solicitation under Amendment 0003.
All other terms and conditions remain the same.
Update #4 ·
Amendment 0003 has been made to allow bids to be submitted by e-mail.
All other terms and conditions remain the same.
Update #3 ·
Amendment 0002 has been made to extend the closing date to February 5, 2025 3:00 PM.
All other terms and conditions remain the same.
Update #2 ·
Amendment 0001 has been made to modify incorrect information on the schedule of supplies stating item 0009 as 100 count when it should have been 1000.
Update #1 ·
Solicitation Attached.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| Doxycycline Hyclate Contract Award SPE2D2-25-D-0015 | Award Notice | |
| This notice | Solicitation | |
| Doxycycline Hyclate | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity